References
- Schön MP, Boehncke WH. Psoriasis. N Engl J Med. 2005;352:1899–1912.
- Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, Lebwohl M. Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. J Am Acad Dermatol. 2007;57:957–962.
- Gelfand JM, Stern RS, Nijsten T, Feldman SR, Thomas J, Kist J, The prevalence of psoriasis in African Americans: Results from a population-based study. J Am Acad Dermatol. 2005;52:23–26.
- Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin. 1996;14:485–496.
- Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc. 2004;9:136–139.
- Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica. 1974;148:1–18.
- Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41:401–407.
- National Psoriasis Foundation. Benchmark Survey. Portland, OR: National Psoriasis Foundation; 2001.
- de Arruda LH, De Moraes AP. The impact of psoriasis on quality of life. Br J Dermatol. 2001;144:33–36.
- Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361:496–509.
- Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol. 1995;132:236–244.
- Javitz HS, Ward MM, Farber E, Nail L, Vallow SG. The direct cost of care for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol. 2002;46:850–860.
- United States Department of Labor, Bureau of Labor Statistics. Consumer Price Index Archived News Releases. Available from: http://www.bls.gov/schedule/archives/cpi_nr.htm (Accessed 2009 November 14).
- Simpson GL, Yelverton CB, Rittenberg S, Feldman SR. Do utilization management controls for phototherapy increase the prescription of biologics? J Dermatolog Treat. 2006;17:359–361.
- Fowler JF, Duh MS, Rovba L, Buteau S, Pinheiro L, Lobo F, The impact of psoriasis on health care costs and patient work loss. J Am Acad Dermatol. 2008;59:772–780.
- Berger K, Ehlken B, Kugland B, Augustin M. Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany. J Dtsch Dermatol Ges. 2005;3:511–518.
- Jenner N, Campbell J, Plunkett A, Marks R. Cost of psoriasis: A study on the morbidity and financial effects of having psoriasis in Australia. Australas J Dermatol. 2002;43:255–261.
- Beyer V, Wolverton SE. Recent trends in systemic psoriasis treatment costs. Arch Dermatol. 2010;146:46–54.
- Agency for Healthcare Research and Quality (AHRQ). Medical Expenditure Panel Survey. Available from: http://www.meps.ahrq.gov/mepsweb (Accessed 2010 April 14).
- Cohen JW, Monheit AC, Beauregard KM, Cohen SB, Lefkowitz DC, Potter DE, The Medical Expenditure Panel Survey: A national health information resource. Inquiry. 1996–1997;33:373–389.
- Agency for Healthcare Research and Quality (AHRQ). MEPS-HC Panel Design and Collection Process. Available from: http://www.meps.ahrq.gov/survey_comp/hc_data_collection.jsp (Accessed 2010 April 14).
- Lee DW, Meyer JW, Clouse J. Implications of controlling for comorbid conditions in cost-of-illness estimates: A case study of osteoarthritis from a managed care system perspective. Value Health. 2001;4:329–334.
- Cragg JG. Some statistical models for limited dependent variables with application to the demand for durable goods. Econometrica. 1971;39:829–844.
- Buntin M, Zaslavsky A. Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. J Health Econ. 2004;23:525–542.
- Mullahy J. Much ado about two: Reconsidering retransformation and the two-part model in health econometrics. J Health Econ. 1998;17:247–281.
- Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA. Insurer and out-of-pocket costs of osteoarthritis in the US: Evidence from national survey data. Arthritis Rheum. 2009;60:3546–3553.
- U.S. Bureau of the Census. Population estimates. Available from: http://www.census.gov/popest/national/national.html (Accessed 2010 April 14).
- Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit Kremers H. Trends in incidence of adult-onset psoriasis over three decades: A population-based study. J Am Acad Dermatol. 2009;60:394–401.
- U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General information and national estimates on diabetes in the United States, 2007. Available from: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf (Accessed 2010 April 14).
- National Institutes of Health. Incidence and Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases. Bethesda, MD: National Heart, Lung and Blood Institute; May 2006. Available from: http://www.nhlbi.nih.gov/resources/docs/06a_ip_chtbk.pdf (Accessed 2010 April 14).
- United States Department of Labor, Bureau of Labor Statistics. National Compensation Survey: Occupational Wages in the United States, July 2003 (Bulletin 2568). September 2004. Available from: http://stats.bls.gov/ncs/ocs/sp/ncbl0658.pdf (Accessed 2010 April 14).
- Blumenthal D. Employer-sponsored insurance—Riding the health care tiger. N Engl J Med. 2006;355:195–202.
- Blumenthal D. Employer-sponsored health insurance in the United States—Origins and implications. N Engl J Med. 2006;355:82–88.
- Collins SR, Davis K, Ho A. A shared responsibility. US employers and the provision of health insurance to employees. Inquiry. 2005;42:6–15.
- Machlin S, Cohen J, Elixhauser A, Beauregard K, Steiner C. Sensitivity of household reported medical conditions in the medical expenditure panel survey. Med Care. 2009;47:618–625.